Login Register Cart 0
Generic placeholder image

Current Organic Synthesis

Editor-in-Chief

ISSN (Print): 1570-1794
ISSN (Online): 1875-6271

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Imidazole and Derivatives Drugs Synthesis: A Review

Author(s): Nidhi Rani*, Randhir Singh and Praveen Kumar

Volume 20, Issue 6, 2023

Published on: 13 January, 2023

Page: [630 - 662] Pages: 33

DOI: 10.2174/1570179420666221118100525

Price: $65

Abstract

Imidazoles have long held a special place in heterocyclic chemistry, and their derivatives have piqued interest in recent years due to their diverse chemistry and pharmacology features. Imidazole is a biologically and pharmaceutically important nitrogen-containing heterocyclic ring. As a result, researchers have been interested in imidazole molecules. For a century and a half, purine, histamine, and other natural compounds all contained the imidazole ring. A number of imidazole drugs have been prepared and marketed for the treatment of various diseases. In view of this, we herein report a detailed account of synthetic procedures for various imidazole drugs.

« Previous Next »
Graphical Abstract

[1]
Shiri, P.; Amani, A.M.; Mayer-Gall, T. A recent overview on the synthesis of 1,4,5-trisubstituted 1,2,3-triazoles. Beilstein J. Org. Chem., 2021, 17, 1600-1628.
[http://dx.doi.org/10.3762/bjoc.17.114] [PMID: 34354770]
[2]
Alam, O.; Naim, M.J.; Nawaz, F.; Alam, M.J.; Alam, P. Current status of pyrazole and its biological activities. J. Pharm. Bioallied Sci., 2016, 8(1), 2-17.
[http://dx.doi.org/10.4103/0975-7406.171694] [PMID: 26957862]
[3]
Sheehan, D.J.; Hitchcock, C.A.; Sibley, C.M. Current and emerging azole antifungal agents. Clin. Microbiol. Rev., 2020, 12(1), 40-79.
[http://dx.doi.org/10.1128/CMR.121.40] [PMID: 9880474]
[4]
Chhabria, M.T.; Patel, S.; Modi, P.; Brahmkshatriya, P.S. Thiazole: A review o chemistry, synthesis and therapeutic importance of its de-rivatives. Curr. Top. Med. Chem., 2016, 16(26), 2841-2862.
[http://dx.doi.org/10.2174/1568026616666160506130731] [PMID: 27150376]
[5]
Moro, J.; Tomé, D.; Schmidely, P.; Demersay, T.C.; Azzout-Marniche, D. Histidine: A systematic review on metabolism and physiological effects in Human and different animal species. Nutrients, 2020, 12(5), 1414.
[http://dx.doi.org/10.3390/nu12051414] [PMID: 32423010]
[6]
Rani, N.; Sharma, A.; Singh, R. Trisubstituted Imidazole Synthesis: A Review. Mini Rev. Org. Chem., 2014, 12(1), 34-65.
[http://dx.doi.org/10.2174/1570193X11666141028235010]
[7]
Gupta, G.; Rani, N.; Kumar, V. Microwave assisted synthesis of imidazoles - a review. Mini Rev. Org. Chem., 2012, 9(3), 270-284.
[http://dx.doi.org/10.2174/1570193X11209030270]
[8]
Rani, N.; Sharma, A.; Gupta, G.; Singh, R. Imidazoles as potential antifungal agents: a review. Mini Rev. Med. Chem., 2013, 13(11), 1626-1655.
[http://dx.doi.org/10.2174/13895575113139990069] [PMID: 23815583]
[9]
Rani, N.; Sharma, A.; Singh, R. Imidazoles as promising scaffolds for antibacterial activity: a review. Mini Rev. Med. Chem., 2013, 13(12), 1812-1835.
[http://dx.doi.org/10.2174/13895575113136660091] [PMID: 24032508]
[10]
De Luca, L. Naturally occurring and synthetic imidazoles: their chemistry and their biological activities. Curr. Med. Chem., 2006, 13(1), 1-23.
[http://dx.doi.org/10.2174/092986709787002826] [PMID: 16457636]
[11]
Gupta, P.; Gupta, J.K. Synthesis of bioactive imidazoles: a review. Chem. Sci. J., 2015, 6(2), 91.
[http://dx.doi.org/10.4172/2150-3494.100091]
[12]
Rani, N.; Gupta, G.K.; Kumar, V. Imidazole: A potential scaffold for antimicrobial activity. Global J. Pharm. Edu. Res., 2013, 1, 7-16.
[13]
Rani, N.; Kumar, P.; Singh, R.; de Sousa, D.P.; Sharma, P. Current and future prospective of a versatile moiety: imidazole. Curr. Drug Targets, 2020, 21(11), 1130-1155.
[http://dx.doi.org/10.2174/1389450121666200530203247] [PMID: 32472996]
[14]
Atia, A.J.K. Synthesis and antibacterial activities of new metronidazole and imidazole derivatives. Molecules, 2009, 14(7), 2431-2446.
[http://dx.doi.org/10.3390/molecules14072431] [PMID: 19633614]
[15]
Johannes, K.A.; Einari, V.R.; Juhani, S.E. Optical isomers of an imidazole derivative. Patent GB2206880, 1987.
[16]
Karjalanien, A.J.; Kurkela, K.O.A. Antihypertensive substituted imidazole derivatives. Patent US4544664A, 1985.
[17]
Kudzma, L.V.; Turnbull, S.P. Jr Expedient Synthesis of 4(5)-[1-(2,3-Dimethylphenyl)ethyl]-1 H -imidazole, the α2 -Adrenergic Agonist Medetomidine. Synthesis, 1991, 1991(11), 1021-1022.
[http://dx.doi.org/10.1055/s-1991-26637]
[18]
Cordi, A.A.; Persigand, T.; Lecouvé, J.P. Efficient synthesis of (S)-4(5)-[1-(2,3-Dimethylphenyl) ethyl]imidazole tartrate, the potent α 2 adrenoceptor agonist dexmedetomidine. Synth. Commun., 1996, 26(8), 1585-1593.
[http://dx.doi.org/10.1080/00397919608003527]
[19]
Reine, I.; Zandersons, A. Method of preparing medetomidine and its salts. Patent EP1918282A1, 2008.
[20]
Somaiya, R.; Raza, M.; Cranke, J.; Bragg, K. Process for preparation of medetomidine. Patent WO2009053709A1, 2009.
[21]
Thanukrishnan, K.; Balaraman, S. Process for preparation of medetomidine. Patent WO2011070069A1, 2011.
[22]
Bobošíková, M.; Mathia, F.; Végh, D.; Marchalín, S.; Halinkovičová, M. Synthetic approaches to dexmedetomidine. Acta Chim. Slov., 2013, 6(2), 240-244.
[http://dx.doi.org/10.2478/acs-2013-0037]
[23]
Vardanyan, R.S.; Hruby, V.J. Synthesis of Essential Drugs; Elsevier Science, 2006, pp. 1-617.
[24]
Fred, G.E.; Eijcken, C.A.M. Imidazole carboxylates. U.S. Patent 3354173A. 1967.
[25]
Janssen, P.A.J.; Niemegeers, C.G.E.; Lschllekens, K.H.; Lenaerts, F.M. Arzneimittelforschung, 1971, 21, 123.
[26]
Kovac, M.; Miklovicz, T.; Li, L.; Russell, J.; Canales Candela, R.; Aigbirhio, F.; Boros, I. A simple and efficient automated cGMP-compliant radiosynthesis of [ 11 C]metomidate using solid phase extraction cartridge purification. J. Labelled Comp. Radiopharm., 2019, 62(4), 190-197.
[http://dx.doi.org/10.1002/jlcr.3711] [PMID: 30690759]
[27]
Pinne, A. Ueber Hydantoïne. Ber. Dtsch. Chem. Ges., 1888, 21(2), 2320-2329.
[http://dx.doi.org/10.1002/cber.18880210226]
[28]
Anticonvulsant 3-ethyl-5-phenyl hydantoin unit dosages and method of using same. U.S. Patent 2793157, 1888.
[29]
Elati, C.R.; Gangula, S.; Naredla, A.; Ashok, S.; Bhattacharya, A.; Bandichhor, R.; Chandrashekar, R. Novel synthesis of fosphenytoin: anti-convulsant prodrug. Synth. Commun., 2008, 38(17), 2950-2957.
[http://dx.doi.org/10.1080/00397910802005281]
[30]
Biltz, H. Über die Konstitution der Einwirkungsprodukte von substituierten Harnstoffen auf Benzil und über einige neue Methoden zur Darstellung der 5.5‐Diphenyl‐hydantoine. Ber. Dtsch. Chem. Ges., 1908, 41(1), 1379-1393.
[http://dx.doi.org/10.1002/cber.190804101255]
[31]
Henze, H.R.; Tex, A. Method for obtaining hydantoins. U.S. Patent 2409754, 1946.
[32]
Kadam, S.S.; Mahadik, K.R.; Bothara, K.G. Synthesis of biologically active N-alkyl and N-acyl 2-(4-Thiazolyl) -1H-Benzimidazole. OCAIJ, 2007, 3(1), 34-36.
[33]
Zhang, H.H.; An, Y.L.; Xin, W-X.; Zhao, S-Y. An improved procedure for the preparation of apraclonidine hydrochloride. Org. Prep. Proced. Int., 2016, 48(5), 401-404.
[http://dx.doi.org/10.1080/00304948.2016.1206429]
[34]
Naik, A.M.; Sawant, S.D.; Kavishwar, G.A. Novel process for the synthesis of brimonidine and derivative. Int. J. Pharm. Tech. Res., 2010, 2(1), 14-17.
[35]
Danielewicz, J.C.; Snarey, M.; Thomas, G.N.G.N. (2-imidazolin-2-y(amino)substituted quinolones, -quinoxalines and quinazolines as atihypertensive agents. US Patent 3890319A, 1975.
[36]
Burke, J.; Garst, M.E.; Wheeler, L.A. Methods for using (2-imidazolin-2-ylamino)quinoxaline derivatives. US Patent 6323204B1, 2001.
[37]
Глушков, Роберт Георгиевич Robert Glushkov (RU) Mamaeva (RU), Irina Efimovna Mamaeva, Method for preparaing 5-bromo-6- [(2-imidazolin-2-yl)amino]. RU Patent 2285003C1, 2006.
[38]
Gluchowski, C. Method for producing amino-2-imidazoline derivatives. US Patent 5130441A, 1992.
[39]
Ayyangar, N.R.; Brahme, K.C.; Srinivasan, K.V. A novel synthesis of clonidine, an anti-hypertensive drug from o-chloronitrobenzene. Synthesis, 1987, 1987(1), 64-65.
[http://dx.doi.org/10.1055/s-1987-27847]
[40]
Stoilov, I.; Watt, D.S.; Goodman, J.P.; Pyrek, J.S.T. Synthesis of detomidine and medetomidine metabolites: 1,2,3-trisubstituted arenes with 4′(5′)-imidazolylmethyl groups. J. Heterocycl. Chem., 1993, 30(6), 1645-1651.
[http://dx.doi.org/10.1002/jhet.5570300631]
[41]
Ohwaki, K.; Yokogoshi, K.; Niino, H. A process for making a benzothiadiazole derivative. Patent EP0644192A1, 1995.
[42]
Karjalainen, A.J. Specific α2-adrenoreceptor antagonist. EP Patent 183492, 1986.
[43]
Tachibana, K.; Watanabe, T.; Sekizawa, Y.; Takematsu, T. Inhibition of glutamine synthetase and quantitative changes of free amino acids in shoots of bialaphos treated Japanese barnyard millet. J. Pest Sci., 1986, 11, 27.
[44]
Karjalainen, A.J.; Viranten, R.E. Substituted imidazole derivatives and their preparation and use. Patent US5292887A, 1994.
[45]
Wong, W.C.; Gluchowski, C. A concise synthesis of Atipamezole. Synthesis, 1995, 1995(2), 139-140.
[http://dx.doi.org/10.1055/s-1995-3884]
[46]
Staneva, T. Moxonidine synthesis with the aid of organic bases. Patent WO2014037391A1, 2014.
[47]
Preobrashenski, N.A.; Wompe, A.F.; Preobrashenski, W.A. Struktur und Synthese des Iso‐pilocarpins (II. Mitteil.). Ber. Dtsch. Chem. Ges. B, 1933, 66(9), 1187-1193.
[http://dx.doi.org/10.1002/cber.19330660903]
[48]
Preobrashenski, N.A.; Wompe, A.F.; Preobrashenski, W.A.; Schtschukina, M.N. Über Alkaloide der Jaborandi‐Blätter, III. Mitteil.: Syn-these des Pilocarpins und des Pilocarpidins. Ber. Dtsch. Chem. Ges. B, 1933, 66(10), 1536-1541.
[http://dx.doi.org/10.1002/cber.19330661017]
[49]
Preobrashenski, N.A.; Poljakowa, A.M.; Preobrashenski, W.A. Über die Alkaloide der Jaborandi‐Blätter, VIII. Mitteil.: Die Synthese der d ‐Homo‐pilopsäure. Ber. Dtsch. Chem. Ges. B, 1935, 68(5), 850-852.
[http://dx.doi.org/10.1002/cber.19350680523]
[50]
DeGraw, J.I. An improved synthesis of pilocarpine. Tetrahedron, 1972, 28(4), 967-972.
[http://dx.doi.org/10.1016/0040-4020(72)80156-X]
[51]
Link, H.; Bernauer, K. [Synthesis of the pilocarpus alkaloids isopilosin and pilocarpine as well as the absolute configuration of the (+)isopilosins]. Helv. Chim. Acta, 1972, 55(4), 1053-1062.
[http://dx.doi.org/10.1002/hlca.19720550402] [PMID: 5036608]
[52]
Noordam, A.; Maat, L.; Beyerman, H.C. Stereoselective synthesis of (+)-pilocarpine, an imidazole alkaloid used in ophthalmology (Imid-azole Chemistry, Part VII). Recl. Trav. Chim. Pays Bas, 1979, 98(7-8), 467-468.
[http://dx.doi.org/10.1002/recl.19790980711]
[53]
Langenbeck, W. Hauptversammlung der Deutschen Bunsen-Gesellschaft für angewandte physikalische Chemie vom 7.–10. Oktober 1948 in Stuttgart. Angew. Chem., 1948, 60, 297.
[54]
van Rossum, J.M.; Cornelissen, M.J.W.J.; de Groot, C.T.P.; Hurkmans, J.A.T.M. A new view on an old drug: Pilocarpine. Experientia, 1960, 16(8), 373-375.
[http://dx.doi.org/10.1007/BF02157914] [PMID: 14439327]
[55]
Compagnone, R.S.; Rapoport, H. Chirospecific synthesis of (+)-pilocarpine. J. Org. Chem., 1986, 51(10), 1713-1719.
[http://dx.doi.org/10.1021/jo00360a015]
[56]
Hans, I.; Nenri, S.; Ernst, U. Process for the preparation of imidazolines. U.S. Patent 2,505,248A, 1950.
[57]
Wong, W.C.; Gluchowski, C. A concise synthesis of Atipamezole. Synthesis, 1995, 1995(2), 139-140.
[58]
Dash, P.; Kudav, D.P.; Parihar, J.A. A new and convenient synthesis of antazoline derivatives. J. Heterocycl. Chem., 2006, 43(2), 401-404.
[http://dx.doi.org/10.1002/jhet.5570430221]
[59]
Durant, G.J.; Emmett, J.C.; Ganellin, C.R.; Miles, P.D.; Parsons, M.E.; Prain, H.D.; White, G.R. Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine. J. Med. Chem., 1977, 20(7), 901-906.
[http://dx.doi.org/10.1021/jm00217a007] [PMID: 17751]
[60]
Gokhale, N.G.; Chandrashekhar, M.; Rao, P.S. Process for the preparation of eprosartan. Patent WO2011/004384A2, 2011.
[61]
Carini, D.J.; Duncia, J.V.; Aldrich, P.E.; Chiu, A.T.; Johnson, A.L.; Pierce, M.E.; Price, W.A.; Santella, J.B., III; Wells, G.J.; Wexler, R.R. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active anti-hypertensives. J. Med. Chem., 1991, 34(8), 2525-2547.
[http://dx.doi.org/10.1021/jm00112a031] [PMID: 1875348]
[62]
Negishi, E.; King, A.O.; Okukado, N. Selective carbon-carbon bond formation via transition metal catalysis. 3. A highly selective synthesis of unsymmetrical biaryls and diarylmethanes by the nickel- or palladium-catalyzed reaction of aryl- and benzylzinc derivatives with aryl halides. J. Org. Chem., 1977, 42(10), 1821-1823.
[http://dx.doi.org/10.1021/jo00430a041]
[63]
Saari, W.S.; Hoffman, J.M.; Wai, J.S.; Fisher, T.E.; Rooney, C.S.; Smith, A.M.; Thomas, C.M.; Goldman, M.E.; O’Brien, J.A.; Nunberg, J.H. 2-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors. J. Med. Chem., 1991, 34(9), 2922-2925.
[http://dx.doi.org/10.1021/jm00113a036] [PMID: 1716683]
[64]
Larsen, R.D.; King, A.O.; Chen, C.Y.; Corley, E.G.; Foster, B.S.; Roberts, F.E.; Yang, C.; Lieberman, D.R.; Reamer, R.A.; Tschaen, D.M.; Verhoeven, T.R.; Reider, P.J.; Lo, Y.S.; Rossano, L.T.; Brookes, A.S.; Meloni, D.; Moore, J.R.; Arnett, J.F. Efficient synthesis of losartan, a nonpeptide angiotensin ii receptor antagonist. J. Org. Chem., 1994, 59(21), 6391-6394.
[http://dx.doi.org/10.1021/jo00100a048]
[65]
Seki, M. 2,4-dimethoxybenzyl group for the protection of tetrazole: An efficient synthesis of olmesartan medoxomil through C-H aryla-tion. Synthesis, 2015, 47(19), 2985-2990.
[http://dx.doi.org/10.1055/s-0034-1378848]
[66]
Das, D.; Roy, G.; Mugesh, G. Antithyroid drug carbimazole and its analogues: synthesis and inhibition of peroxidase-catalyzed iodination of L-tyrosine. J. Med. Chem., 2008, 51(22), 7313-7317.
[http://dx.doi.org/10.1021/jm800894m] [PMID: 18954039]
[67]
Yefa, Q.; Qianqi, W.; Xinmin, Z.; Jianguo, S. Synthetic method of enilconazole. Patent CN104876873A, 2015.
[68]
Mangas-Sánchez, J.; Busto, E.; Gotor-Fernández, V.; Malpartida, F.; Gotor, V. Asymmetric chemoenzymatic synthesis of miconazole and econazole enantiomers. The importance of chirality in their biological evaluation. J. Org. Chem., 2011, 76(7), 2115-2122.
[http://dx.doi.org/10.1021/jo102459w] [PMID: 21384803]
[69]
Available from: http;//m.chemicalbook.com/chemicalproduct-peopert_EN_CB31178592
[70]
Ogata, M.; Matsumoto, H.; Hamada, Y.; Takehara, M.; Tawara, K. 1-[ 1-[2-[ (3-Chlorobenzyl)oxy]phenyl]vinyl]- lH-imidazole Hydro-chloride, a New Potent Antifungal Agent. J. Med. Chem., 1983, 26, 768-770.
[http://dx.doi.org/10.1021/jm00359a026] [PMID: 6842519]
[71]
Sriram, D.; Yogeeswari, P. Medicinal Chemistry, 2nd edition; 498.
[72]
Jiangsu Luye Agrochemicals Co. Ltd., Climbazole synthesizing process. CN100532366C, 2009.
[73]
El Hage, S.; Lajoie, B.; Feuillolay, C.; Roques, C.; Baziard, G. Synthesis, antibacterial and antifungal activities of bifonazole derivatives. Arch. Pharm. (Weinheim), 2011, 344(6), 402-410.
[http://dx.doi.org/10.1002/ardp.201000304] [PMID: 21433056]
[74]
Venkateswarlu Rayudu, S.; Kumar, P. An Easy, Efficient and Improved Synthesis of Sertaconazole Nitrate. Russ. J. Org. Chem., 2019, 55(8), 1212-1216.
[http://dx.doi.org/10.1134/S1070428019080219]
[75]
Shichun, Ji.; Qin, Li.; Mingming, Z. Method of preparaing isoconazole nitrate. Patent CN102399192A, 2012.
[76]
Xiang Yu Pharmaceutical limited company. Fenticonazole nitrate and synthesis process thereof. Patent CN103349755A, 2014.
[77]
Flutrimazole, UR-4056, Drug future. 1888.
[78]
Fonseca, T.S.; Lima, L.D.; de Oliveira, M.C.F.; de Lemos, T.L.G.; Zampieri, D.; Molinari, F.; de Mattos, M.C. Chemoenzymatic synthesis of luliconazole mediated by lipases. Eur. J. Org. Chem., 2018, 2018(18), 2110-2116.
[http://dx.doi.org/10.1002/ejoc.201800250]
[79]
Thiele, K.; Zirngibl, L.; Pfenninger, M.H. Antimycotic imidazolyl-alkenes. Synthesis and X-ray crystal structure of omoconazole. Helv. Chim. Acta, 1987, 70(2), 441-444.
[http://dx.doi.org/10.1002/hlca.19870700224]
[80]
Gymer, G.E. 1-Aryl-2-(1-imidazolyl) alkyl ethers and thioethers. Patent US 4062966, 1977.
[81]
Mixich, G.; Thiele, K. Process for the stereospecific preparation of (Z)-1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)-0-(2,4-dichlorobenzyl)-ethanone oxime ether. Patent US 4550175A, 2002.
[82]
Jun, W.; Pingyue, D.; Keqi, Z.; Jiajia, Z.; Zhonghua, W.; Jun, F. New preparation method of lanoconazole. Patent CN101701017A, 2010.
[83]
Jiangsu Yunyang Pharmaceutical Group Co Ltd. A kind of preparation method of Naconazole. Patent CN107556245B, 2021.
[84]
Anjaneyulu, B.; Nagarajan, K.; Synthes, I.S. Of [ Iflioazolioindne-2-14c]Go 102 13 (Satranidazole, Ciemio@). Labelled Comp. Radiophar-maceuticals-Xxw, 1888, (4), 423-430.
[85]
New Drug Approvals. Available from: https://newdrugapprovals. org/2017/11/03/Secnidazole
[86]
Verdi, V.F. Process for the preparation of nitroimidazole. Patent US 3450710A 1969.
[87]
Watson, L. Method of making benznidazole. Patent WO 2017/205622, 2017.
[88]
Zarda, A.; Zibulski, D.; Wartusch, M.; Wormann, T.; Zurmuhl, S. Telithromycin. 2017.
[89]
Shealy, Y.F.; Krauth, C.A.; Montgomery, J.A. Imidazoles. I. Coupling Reactions of 5-Diazoimidazole-4-carboxamide 1,2. J. Org. Chem., 1962, 27(6), 2150-2154.
[http://dx.doi.org/10.1021/jo01053a060]
[90]
Seuron, P.; Varraillon, D. Process for 1-phenyl-imidazoline-2,5-diones. Patent US 5166358, 1992.
[91]
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof. Patent WO2004054498, 1888.
[92]
Takita, T.; Umezawa, Y.; Saito, S.; Morishima, H.; Naganawa, H.; Umezawa, H.; Tsuchiya, T.; Miyake, T.; Kageyama, S.; Umezawa, S.; Muraoka, Y.; Suzuki, M.; Otsuka, M.; Narita, M.; Kobayashi, S.; Ohno, M. Total synthesis of bleomycin A2. Tetrahedron Lett., 1982, 23, 521.
[http://dx.doi.org/10.1016/S0040-4039(00)86878-1]
[93]
Aoyagi, Y.; Katano, K.; Suguna, H.; Primeau, J.; Chang, L.H.; Hecht, S.M. Total synthesis of bleomycin. J. Am. Chem. Soc., 1982, 104(20), 5537-5538.
[http://dx.doi.org/10.1021/ja00384a067]
[94]
Saito, S.I.; Umezawa, Y.; Yoshioka, T.; Takita, T.; Umezawa, H.; Muraoka, Y. An improved total synthesis of bleomycin. J. Antibiot., 1983, 36(1), 92-95.
[http://dx.doi.org/10.7164/antibiotics.36.92] [PMID: 6206046]
[95]
Boger, D.L.; Honda, T. Total synthesis of bleomycin A2 and related agents. 4. Synthesis of the disaccharide subunit 2-O-(3-O-carbamoyl-.alpha.-D-mannopyranosyl)-L-gulopyranose and completion of the total synthesis of bleomycin A2. J. Am. Chem. Soc., 1994, 116(13), 5647-5656.
[http://dx.doi.org/10.1021/ja00092a014]
[96]
Katano, K.; An, H.; Aoyagi, Y.; Overhand, M.; Sucheck, S.J.; Stevens, W.C.; Hess, C.D.; Zhou, X.; Hecht, S.M. Total synthesis of bleomy-cin group antibiotics. total syntheses of bleomycin demethyl A 2, bleomycin A 2, and decarbamoyl bleomycin semethyl A 2. J. Am. Chem. Soc., 1998, 120(44), 11285-11296.
[http://dx.doi.org/10.1021/ja9819458]
[97]
Yeh, C.; Chen, C. Process for preparing imidacloprid. Patent US6307053B1, 2001.
[98]
Hayashi, M.; Hirano, T.; Yaso, M.; Mizuno, K.; Ueda, T. Studies on bredinin. III. Chemical synthesis of bredinin. (A novel imidazole nucleoside). Chem. Pharm. Bull., 1975, 23(1), 245-246.
[http://dx.doi.org/10.1248/cpb.23.245]
[99]
Horton, J.K.; Stevens, M.F.G. A new light on the photo-decomposition of the antitumour drug DTIC. J. Pharm. Pharmacol., 1981, 33(12), 808-811.
[PMID: 6121862]
[100]
Tarumi, Y.; Atsumi, T. Studies on imidazole derivatives and related compounds. 2. Characterization of substituted derivatives of 4-carbamoylimidazolium-5-olate by ultraviolet absorption spectra. J. Heterocycl. Chem., 1983, 20(4), 875-885.
[http://dx.doi.org/10.1002/jhet.5570200408]
[101]
Tarumi, Y.; Takebayashi, Y.; Atsumi, T. Studies on imidazole derivatives and related compounds. 4. Synthesis of O -glycosides of 4-carbamoylimidazolium-5-olate. J. Heterocycl. Chem., 1984, 21(3), 849-854.
[http://dx.doi.org/10.1002/jhet.5570210342]
[102]
Tarumi, Y.; Moriguchi, K.; Atsumi, T. Studies on imidazole derivatives and related compounds. 3. Regioselective glycosylation of 4-carbamoylimidazolium-5-olate. J. Heterocycl. Chem., 1984, 21(2), 529-537.
[http://dx.doi.org/10.1002/jhet.5570210253]
[103]
Humble, R.W.; Middleton, D.F.; Banoub, J.; Ewing, D.F.; Boa, A.N.; Mackenzie, G. A synthesis of bredinin (Mizoribine®) from an acyclic precursor. Tetrahedron Lett., 2011, 52(47), 6223-6227.
[http://dx.doi.org/10.1016/j.tetlet.2011.09.085]
[104]
Human, Iven Bio-technology Co. Ltd. Preparation method of nizofenone. Patent CN102718716A, 2012.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy